Skip to main content
QUCY
NASDAQ Life Sciences

Quantum Cyber Terminates ATM Program After Raising $4.4M, Shifts to Larger $250M Shelf Registration

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$2.15
Mkt Cap
$50.088M
52W Low
$0.3
52W High
$4.93
52W Position info
617% above low
Off High info
56% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

QUCY has more than doubled off its 52-week low of $0.3 on light trading volume (0.1× avg).

Summary

Quantum Cyber N.V. terminated its ATM program after raising $4.39 million, transitioning to a new, larger $250 million universal shelf registration for future capital needs.


Key Events · Financing and Capital Events · QUCY

  • ATM Program Terminated

    Quantum Cyber N.V. delivered notice to Maxim Group LLC to terminate its at-the-market (ATM) issuance sales agreement, effective June 7, 2026. No termination penalties apply.

  • Significant Capital Raised Under ATM

    Prior to termination, the company sold 3,280,927 Ordinary Shares under the ATM agreement, generating net cash proceeds of approximately $4,388,515.

  • Transition to Larger Shelf Registration

    This termination follows the company's filing of a new $250 million universal shelf registration on June 4, 2026, indicating a shift to a larger capital raising vehicle.


Analysis · QUCY · Life Sciences

Quantum Cyber N.V. terminated its at-the-market (ATM) sales agreement with Maxim Group LLC, which was previously expanded to $100 million on May 8, 2026. Prior to termination, the company sold approximately 3.28 million shares, raising $4.39 million. This termination, however, comes just two days after the company filed a new $250 million universal shelf registration, indicating a strategic shift to a larger and more flexible capital raising mechanism. The company continues to actively seek capital, which will likely result in further dilution for existing shareholders.

At the time of this filing, QUCY was trading at $2.15 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $50.1M. The 52-week trading range was $0.30 to $4.93. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

QUCY - Latest Insights

QUCY
Jul 06, 2026, 6:09 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.40
Real-time Price: $1.17 info
Change: -$0.230 (-16%) info
Market Cap: $26.41M info
QUCY
Jul 01, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.54
Real-time Price: $1.17 info
Change: -$0.370 (-24%) info
Market Cap: $26.41M info
QUCY
Jun 30, 2026, 3:13 AM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $1.56
Real-time Price: $1.17 info
Change: -$0.390 (-25%) info
Market Cap: $26.41M info
QUCY
Jun 29, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.56
Real-time Price: $1.17 info
Change: -$0.392 (-25%) info
Market Cap: $26.41M info
QUCY
Jun 26, 2026, 5:00 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.60
Real-time Price: $1.17 info
Change: -$0.425 (-27%) info
Market Cap: $26.41M info